Know How Descovy and Truvada Stack Up for HIV Pre-Exposure Prophylaxis (PrEP)

November 2019

Descovy will join Truvada as an option for HIV pre-exposure prophylaxis (PrEP)...in the midst of efforts to expand PrEP access.

The U.S. Preventive Services Task Force is chiming in...highlighting the importance of offering PrEP in the primary care setting.

The goal is to PREVENT HIV in high-risk patients...such as men who have unprotected sex with men and people who use IV drugs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Put Concerns About Ranitidine and Drug Safety in Perspective
Heart Failure Don't Jump to an SGLT2 Inhibitor for Heart Failure
Medicare Avoid Pitfalls With Medicare Rxs for DME
Diabetes Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus
Diabetes Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia
HIV & AIDS Know How Descovy and Truvada Stack Up for HIV Pre-Exposure Prophylaxis (PrEP)
Alcohol Be Ready to Answer the Question, "Is It Okay to Drink Alcohol With This Med?"
Pain Management Consider Acute Pain Management Options for Patients on Buprenorphine/Naloxone
Breast Cancer Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer
Dermatology Set Realistic Expectations for Patients Asking About Scar Treatments